CN113444097A - 三并咔唑衍生物、有机光电器件及显示或照明装置 - Google Patents

三并咔唑衍生物、有机光电器件及显示或照明装置 Download PDF

Info

Publication number
CN113444097A
CN113444097A CN202111001493.7A CN202111001493A CN113444097A CN 113444097 A CN113444097 A CN 113444097A CN 202111001493 A CN202111001493 A CN 202111001493A CN 113444097 A CN113444097 A CN 113444097A
Authority
CN
China
Prior art keywords
organic
substituted
unsubstituted
layer
except
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111001493.7A
Other languages
English (en)
Inventor
王鹏
王子兴
高春吉
吴利
张迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Huadisplay Optoelectronics Co Ltd
Original Assignee
Zhejiang Huadisplay Optoelectronics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Huadisplay Optoelectronics Co Ltd filed Critical Zhejiang Huadisplay Optoelectronics Co Ltd
Priority to CN202111001493.7A priority Critical patent/CN113444097A/zh
Publication of CN113444097A publication Critical patent/CN113444097A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0816Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H10K50/12OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/16Electron transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • H10K50/171Electron injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/40Organosilicon compounds, e.g. TIPS pentacene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/626Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1037Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1048Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1051Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1055Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • C09K2211/1062Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • C09K2211/1066Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1074Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

本发明公开了一种三并咔唑衍生物、有机光电器件及显示或照明装置,其中该三并咔唑衍生物其具有下列式(1)所示的结构:

Description

三并咔唑衍生物、有机光电器件及显示或照明装置
技术领域
本发明涉及一种三并咔唑衍生物,尤其涉及一种三并咔唑衍生物、有机光电器件及显示或照明装置,属于有机电致发光领域。
背景技术
有机光电器件(例如有机电激发光二极管,简称为OLED)具有薄型且能在低驱动电压下高亮度发光以及能通过选择发光材料而进行多色发光的特点,因此倍受关注。自从由柯达公司的C.W.Tang等揭示有机薄膜元件能以高亮度发光以来,大量OLED 行业研究人员对于其应用,做了很多研究和推进。有机光电器件被广泛应用在各种主显示屏等中,其实用化取得长足的进展。尽管有机电致发光的研究进展非常迅速,但仍有很多亟待解决的问题,例如外量子效率(EQE)仍然需要提高,如何设计与合成出色纯度更高、高效电子传输、空穴阻挡新材料等等。对于有机电致发光器件来说,器件的发光量子效率是各种因素的综合反映,也是衡量器件品质的一重要指标。
电致发光一般可以分为荧光发光和磷光发光。在荧光发光中,单线态激发状态的有机分子跃迁至基态,由此发出光。另一方面,在磷光发光中,三线态激发状态的有机分子跃迁至基态,由此发出光。目前来看,部分有机电致发光材料性能优秀,具有一定的应用价值,但作为有机电致发光器件中的主体材料,除了三线态能级要高于客体材料,防止激子跃迁释放的能量逆传递以外,更重要的是具有良好的空穴迁移性能。然而,目前主体材料中同时具有高三线态能级和良好空穴迁移率的材料仍然缺乏。因此,如何设计具有更好性能的主体材料,一直是本领域技术人员亟待解决的问题。
发明内容
为了克服现有技术中存在的缺陷,本发明的目的是提供一种三并咔唑衍生物及包含该三并咔唑衍生物的有机光电器件,该有机光电器件具有较高的发光效率,同时其寿命也有所提升。
为了实现本发明的目的,本发明的技术方案如下:
本发明提供了一种三并咔唑衍生物,其具有下列式(1)所示的结构:
Figure 218731DEST_PATH_IMAGE001
式(1)。
其中X1-X8各自独立地选自CR或N原子,其中,R选自氢、氘、卤素、氰基、取代或未取代的烷基、环烷基、杂烷基、杂环烷基、芳基或杂芳基。
X1-X8彼此相同或不同,其中,当X1-X8均不为N原子时,R1、R2和R3不全相同或全部不相同。
L1、L2和L3为单键或取代或未取代的芳基。
R1、R2和R3各自独立地选自取代或未取代的C6~C30芳基、取代或未取代的C4~C30杂芳基、或者与邻近的原子键合成环。
R4-R5各自独立地选自氢、取代或未取代的 C1-C15烷基、取代或未取代的C6~C30芳基或取代或未取代的C4~C30杂芳基。
其中,R1、R2和R3中至少一者选自如下取代或未取代的基团:
Figure 853981DEST_PATH_IMAGE002
Figure 368139DEST_PATH_IMAGE003
Figure 701031DEST_PATH_IMAGE004
Figure 941169DEST_PATH_IMAGE005
Figure 498052DEST_PATH_IMAGE006
Figure 686457DEST_PATH_IMAGE007
Figure 619778DEST_PATH_IMAGE008
Figure 757498DEST_PATH_IMAGE009
Figure 173699DEST_PATH_IMAGE010
Figure 662449DEST_PATH_IMAGE011
Figure 337144DEST_PATH_IMAGE012
Figure 578638DEST_PATH_IMAGE013
Figure 477324DEST_PATH_IMAGE014
Figure 391053DEST_PATH_IMAGE015
Figure 148400DEST_PATH_IMAGE016
Figure 463975DEST_PATH_IMAGE017
Figure 267983DEST_PATH_IMAGE018
Figure 715014DEST_PATH_IMAGE019
Figure 528249DEST_PATH_IMAGE020
Figure 698330DEST_PATH_IMAGE021
Figure 955130DEST_PATH_IMAGE022
Figure 577873DEST_PATH_IMAGE023
Figure 194799DEST_PATH_IMAGE024
Figure 468654DEST_PATH_IMAGE025
Figure 145623DEST_PATH_IMAGE026
其中,R6-R10各自独立地选自氢、取代或未取代的 C1-C15烷基、取代或未取代的C6~C30芳基或取代或未取代的C4~C30杂芳基。
并且当R1为上述S-44,且R2和R3不为上述S-44时,L1为单键。
当R2为上述S-44,且R1和R3不为上述S-44时,L2为单键。
当R3为上述S-44,且R1和R2不为上述S-44时,L3为单键。
更优选地,该三并咔唑衍生物为以下结构中任一者:
Figure 21043DEST_PATH_IMAGE027
Figure 176080DEST_PATH_IMAGE028
Figure 320754DEST_PATH_IMAGE029
Figure 417892DEST_PATH_IMAGE030
Figure 15226DEST_PATH_IMAGE031
Figure 973955DEST_PATH_IMAGE032
Figure 255026DEST_PATH_IMAGE033
Figure 211481DEST_PATH_IMAGE034
Figure 358428DEST_PATH_IMAGE035
Figure 104536DEST_PATH_IMAGE036
Figure 958223DEST_PATH_IMAGE037
Figure 882316DEST_PATH_IMAGE038
Figure 202046DEST_PATH_IMAGE039
Figure 502577DEST_PATH_IMAGE040
Figure 725617DEST_PATH_IMAGE041
Figure 820612DEST_PATH_IMAGE042
Figure 879835DEST_PATH_IMAGE043
Figure 734790DEST_PATH_IMAGE044
Figure 297489DEST_PATH_IMAGE045
Figure 563385DEST_PATH_IMAGE046
Figure 155910DEST_PATH_IMAGE047
Figure 1506DEST_PATH_IMAGE048
Figure 481029DEST_PATH_IMAGE049
Figure 937068DEST_PATH_IMAGE050
Figure 705303DEST_PATH_IMAGE051
Figure 885749DEST_PATH_IMAGE052
Figure 734625DEST_PATH_IMAGE053
Figure 545586DEST_PATH_IMAGE054
Figure 597856DEST_PATH_IMAGE055
Figure 332725DEST_PATH_IMAGE056
Figure 990102DEST_PATH_IMAGE057
Figure 34282DEST_PATH_IMAGE058
Figure 823115DEST_PATH_IMAGE059
Figure 814205DEST_PATH_IMAGE060
Figure 73892DEST_PATH_IMAGE061
Figure 288972DEST_PATH_IMAGE062
Figure 50255DEST_PATH_IMAGE063
Figure 828724DEST_PATH_IMAGE064
Figure 257431DEST_PATH_IMAGE065
Figure 581096DEST_PATH_IMAGE066
Figure 111566DEST_PATH_IMAGE067
Figure 975617DEST_PATH_IMAGE068
Figure 196514DEST_PATH_IMAGE069
Figure 268244DEST_PATH_IMAGE070
Figure 4119DEST_PATH_IMAGE071
Figure 875123DEST_PATH_IMAGE072
Figure 754786DEST_PATH_IMAGE073
Figure 685833DEST_PATH_IMAGE074
Figure 909004DEST_PATH_IMAGE075
Figure 629704DEST_PATH_IMAGE076
Figure 825193DEST_PATH_IMAGE077
Figure 989458DEST_PATH_IMAGE078
Figure 388341DEST_PATH_IMAGE079
Figure 663465DEST_PATH_IMAGE080
Figure 228307DEST_PATH_IMAGE081
Figure 297894DEST_PATH_IMAGE082
Figure 495657DEST_PATH_IMAGE083
Figure 994378DEST_PATH_IMAGE084
Figure 226777DEST_PATH_IMAGE085
Figure 201686DEST_PATH_IMAGE086
Figure 339275DEST_PATH_IMAGE087
Figure 956201DEST_PATH_IMAGE088
Figure 777527DEST_PATH_IMAGE089
Figure 142911DEST_PATH_IMAGE090
Figure 315266DEST_PATH_IMAGE091
Figure 407987DEST_PATH_IMAGE092
Figure 598666DEST_PATH_IMAGE093
Figure 180957DEST_PATH_IMAGE094
Figure 575029DEST_PATH_IMAGE095
Figure 225103DEST_PATH_IMAGE096
Figure 286600DEST_PATH_IMAGE097
Figure 243055DEST_PATH_IMAGE098
Figure 639270DEST_PATH_IMAGE099
Figure 73794DEST_PATH_IMAGE100
Figure 724218DEST_PATH_IMAGE101
Figure 867885DEST_PATH_IMAGE102
Figure 502129DEST_PATH_IMAGE103
Figure 537081DEST_PATH_IMAGE104
Figure 494542DEST_PATH_IMAGE105
Figure 855116DEST_PATH_IMAGE106
Figure 662142DEST_PATH_IMAGE107
Figure 235205DEST_PATH_IMAGE108
Figure 125801DEST_PATH_IMAGE109
Figure 844227DEST_PATH_IMAGE110
Figure 921905DEST_PATH_IMAGE111
Figure 829818DEST_PATH_IMAGE112
Figure 263335DEST_PATH_IMAGE113
Figure 965712DEST_PATH_IMAGE114
Figure 999527DEST_PATH_IMAGE115
Figure 366924DEST_PATH_IMAGE116
Figure 966532DEST_PATH_IMAGE117
Figure 839810DEST_PATH_IMAGE118
Figure 860723DEST_PATH_IMAGE119
Figure 579280DEST_PATH_IMAGE120
Figure 298975DEST_PATH_IMAGE121
Figure 530105DEST_PATH_IMAGE122
Figure 335250DEST_PATH_IMAGE123
Figure 857498DEST_PATH_IMAGE124
Figure 120114DEST_PATH_IMAGE125
Figure 69616DEST_PATH_IMAGE126
Figure 96478DEST_PATH_IMAGE127
Figure 874947DEST_PATH_IMAGE128
本发明提供了一种有机光电器件,其包括:第一电极;
第二电极,其与该第一电极相面对;有机层,其夹设于该第一电极和该第二电极之间;其中,该有机层包含本发明的三并咔唑衍生物。
本发明提供了一种有机光电器件,其包括阴极层、阳极层和有机层,其中,该有机层为空穴注入层、空穴传输层、发光层、电子注入层或电子传输层中至少一层;
其中,该有机层包含本发明的三并咔唑衍生物。
优选地,该有机层为发光层,该发光层中还包含掺杂剂,其中该三并咔唑衍生物与该掺杂剂(客体材料)的质量比为1:99~99:1,且该掺杂剂没有任何限制。
优选地,该有机层为电子传输层。
优选地,有机光电器件为有机光伏器件、有机发光器件(OLED)、有机太阳电池(OSC)、电子纸(e-paper)、有机感光体(OPC)、有机薄膜晶体管(OTFT)或有机内存器件(Organic Memory Element)。
本发明还提供了一种显示或照明装置,其包括本发明的有机光电器件。
主体材料同时具有空穴传输性质和电子传输性质,对器件的性能有增益的效果。咔唑基团具有一定的三线态能级,并且有良好的空穴传输能力。本发明的三并咔唑衍生物具有双极性及较平衡的空穴和电子传输性质,因此,其能较好地作为主体材料应用在有机光电元件中。
本发明提供了一种新颖的三并咔唑衍生物,其具有高的三线态能级,并具备有良好的空穴传输能力。在咔唑的N原子上引入缺电子基团,能提高分子的电子传输能力。另外,在氮原子上引入芳香基团也利于分子的合成,较易得到理想的化合物。且咔唑环具有良好的平面性,当多个咔唑环形成并环后,分子的平面性得到进一步的加强,这样更加利于分子间的堆积,有利于减少不必要的振动能量损失,从而实现高效的发光性能。另外,本发明的并三咔唑衍生物制备方法简单,原料易得,能够满足工业化需求。
具体实施方式
本发明的包含咔唑衍生物的有机光电器件包括基板、第一电极、有机物层、第二电极和覆盖层。优选地,该有机光电器件器件包括基板、位于该基板上的第一电极、位于该第一电极上的有机物层、位于该有机物层上的第二电极以及位于该第二电极外侧的覆盖层,其中,该第二电极外侧是指背离该第一电极的一侧。
本发明的有机层为发光层(活性层)、空穴注入层、空穴传输层、电子传输层和电子注入层中至少一层。且该有机层可由单层结构形成,也可由层叠(包括发光层、空穴注入层、空穴传输层、电子传输层和电子注入层的多层)结构形成。其中,该空穴传输层还可包括第一空穴传输层和第二空穴传输层。在本发明的有机光电器件(例如有机电激发光二极管)中,除了该发光层包含本发明的三并咔唑衍生物外,其它层均可以使用本领域公知的用于所述层的任何材料。
在本发明的发光元件中,基板材料可选用典型的有机发光元件中使用的任何基板,例如钠玻璃、无碱玻璃或透明柔性基板、不透明材料如硅或不锈钢的基板或柔性聚酰亚胺薄膜,不同基板材料具有不同的性能,且应用方向不同。本发明的空穴传输层可通过将空穴传输材料中的一种或二种以上层叠或混合的方法,或通过使用空穴传输材料和高分子粘合剂的混合物的方法来形成。空穴传输材料需要在施加了电场的电极之间高效率地传输来自正极的空穴,因此希望空穴注入效率高以及能够高效率地传输注入的空穴。因此,空穴传输材料应当具有适当的电离势及适当的能级并且具有大的空穴迁移率,进一步地,材料稳定性优异且制造及使用过程中不易产生会成为陷阱的杂质。对满足这样条件的物质,没有特别限定,例如可以是咔唑衍生物、三芳胺衍生物、联苯二胺衍生物、芴衍生物、酞菁类化合物、六腈六氮杂苯并菲类化合物、喹吖啶酮类化合物、苝衍生物、蒽醌类化合物、F4-TCNQ、聚苯胺、聚噻吩、聚乙烯咔唑等,但不限于此。
本发明的发光层材料,除了包含本发明的三并咔唑衍生物,还可包含掺杂材料(也称为客体材料)(可包含多个掺杂材料)。另外,发光层可为单一的发光层,也可为横向或纵向叠加在一起的复合发光层。对于掺杂材料的种类选择,可以为荧光材料,也可以为磷光材料;对于掺杂材料的用量选择,优选0.1~70质量%,更优选为0.1~30质量%、进一步优选为1~30质量%、更进一步优选为1~20质量%、特别优选为1~10质量%。本发明的荧光掺杂材料包括:稠合多环芳族衍生物、苯乙烯基胺衍生物、稠环胺衍生物、含硼化合物、吡咯衍生物、吲哚衍生物、咔唑衍生物等,但不限于此;本发明的磷光掺杂材料包括:重金属配合物、磷光发光性的稀土类金属配合物等,但不限于此,其中重金属配合物,例如,可以是铱配合物、铂配合物、锇配合物等;稀土类金属配合物,例如,可以是铽络合物、铕络合物等,但不限于此。本发明的电子传输材料优选具有良好的电子迁移率,同时具有合适的HOMO和LUMO能级,本发明的电子传输材料,例如,可以是金属配合物、氧杂噻唑衍生物、噁唑衍生物、二氮唑衍生物、氮杂苯衍生物、菲罗啉衍生物、二氮蒽衍生物、含硅杂环类化合物、含硼杂环类化合物、氰基类化合物、喹啉衍生物、苯并咪唑衍生物等,但不限于此。本发明的电子注入材料优选具有传输电子能力,同时具有从阴极注入电子的效应,以及具有优异的薄膜形成能力,本发明的电子注入材料,例如,可以是碱金属化合物(例如氧化锂、氟化锂、8-羟基喹啉锂、氧化锂硼、碳酸铯、8-羟基喹啉铯、硅酸钾、氟化钙、氧化钙、氟化镁、氧化镁)、芴酮、含氮五元环衍生物(例如,噁唑衍生物、恶二唑衍生物、咪唑衍生物、金属配合物);蒽醌二甲烷、联苯醌、蒽酮衍生物等,但不限于此,这些化合物可以单独使用,也可与其他材料混合使用。本发明的阴极材料优选具有低功函数,以便容易地将电子注入有机层,本发明的阴极材料例如,可以是金属(例如镁、钙、钠、钾、钛、铟、钇、锂、铝、银、锡、铅或它们的合金)或多层材料(例如LiF/Al或LiO 2 /Al)但不限于此。
本发明的有机层材料,当它们在使用时,可单独成膜形成单层结构,也可和其他材料一起混合成膜形成单层结构,或形成单独成膜的单层的层叠结构、混合成膜的单层的叠层结构、单独成膜的单层和混合成膜的单层的叠层结构,但不限于此。本发明的有机光电器件(例如有机电激发光二极管)可通过依次层叠上述结构而制造。制造方法可使用干式成膜法、湿式成膜法等公知方法,其中干式成膜法,例如,可以是真空蒸镀法、溅射法、等离子体法、离子电镀法等;湿式成膜法例如,可以是旋涂法、浸渍法、流延法、喷墨法等各种涂布法,但不限于此。本发明的有机光电器件(例如有机电激发光二极管)可广泛地应用于面板显示、照明光源、柔性OLED、电子纸、有机太阳能电池、有机感光体或有机薄膜晶体管、指示牌、信号灯等领域。
本发明的有机发光元件为有机光伏器件、有机发光器件(OLED)、有机太阳电池(OSC)、电子纸(e-paper)、有机感光体(OPC)、有机薄膜晶体管(OTFT)及有机内存器件(Organic Memory Element)、照明和显示装置。本发明通式(1)所示的三并咔唑衍生物的合成可以使用本领域公知的方法进行,例如,使用镍、钯等过渡金属的交叉偶合反应,或使用镁或锌等过渡金属的C-C、C-N偶联生成反应。上述反应,限于反应条件温和、各种官能团的选择性优越等特点,优选Suzuki,Buchwald反应。
实施例
本发明的三并咔唑衍生物用以下实施例举例说明,但并不限于这些实施例举例的三并咔唑衍生物和合成方法。
本发明实施例和对比例中采用的初始原料和溶剂购于国药,部分常用的OLED中间体类等产品购于国内的OLED中间体厂商以及各种钯催化剂和配体等购于sigma-Aldrich公司。
1HNMR数据使用JEOL(400MHz)核磁共振仪来测定;HPLC数据使用岛津LC-20AD高效液相仪来测定。
实施例和比较例中使用物质为:
(化合物1)14-苯基-5,8-双(3-苯基喹啉-2-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑。
(化合物5)5,8-二苯基-14-(3-苯基喹啉-2-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑。
(化合物11)14-苯基-5,8-二(吡啶-4-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑。
(化合物19)14-(萘-2-基)-5,8-双(1-苯基-1H-1,2,4-***-3-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑。
(化合物24)2,11-二叔丁基-5,8,14-三(吡啶-4-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑。
(化合物29)2,2',2'-(2,11-二叔丁基-5H-吡咯[3,2-b:4,5-b']二咔唑-5,8,14-三酰基)三(苯并[d]恶唑)。
(化合物38)5,8,14-三(吡啶-4-基)-8,14-二氢-5H-吡啶[2',3':4,5]吡咯[3,2-b]吡咯[2',3':4,5]吡咯[2,3-h]咔唑。
(化合物43)2,2',2'-(5H-吡啶基)[2',3':4,5]吡咯基[3,2-b]吡啶基[2',3':4,5]吡咯基[2,3-h]咔唑-5,8,14-三(苯并[d]恶唑)。
(化合物46)14-(异喹啉-3-基)-5,8-二(喹啉-2-基)-8,14-二氢-5H-吡啶[3',4':4,5]吡咯[3,2-b]吡咯[3',4':4,5]吡咯[2,3-h]咔唑。
(化合物54)5,8,14-三(喹啉-5-基)-8,14-二氢-5H-吡啶[3,4]:4,5]吡咯[3,2-b]吡咯[3,4]:4,5]吡咯[2,3-h]咔唑。
(化合物68)5,8,14-三(吡啶-4-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑-2,11-二甲腈。
(化合物88)5,8,14-三(吡嗪-2-基)-8,14-二氢-5h-吡啶[3,4]:4,5]吡咯[3,2-b]吡啶[3,4]:4,5]吡咯[2,3-h]咔唑。
(化合物93)5,8,14-三(4-(吡啶-4-基)苯基)-8,14-二氢-5H-吡啶[2',3':4,5]吡咯[3,2-b]吡咯[2',3':4,5]吡咯[2,3-h]咔唑。
(化合物145)14-(1,10-菲咯啉-2-基)-5,8-二苯基-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑。
(化合物148)14-(1,10-菲咯啉-2-基)-2,5,8,11-四苯基-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑。
(化合物184)14-(3-(1,8-萘啶-4-基)苯基)-5,8-二(萘-2-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑。
Figure 303654DEST_PATH_IMAGE129
Figure 424057DEST_PATH_IMAGE130
Figure 889280DEST_PATH_IMAGE131
Figure 18910DEST_PATH_IMAGE132
Figure 36544DEST_PATH_IMAGE133
Figure 45957DEST_PATH_IMAGE134
合成路线如下:
Figure 250674DEST_PATH_IMAGE135
Figure 669148DEST_PATH_IMAGE136
实施例1
化合物1的合成
Figure 10131DEST_PATH_IMAGE137
(1)在氩气气氛下,反应容器中加入2,7-二溴-9-苯基-9H-咔唑40.1克(100mmol), (2-硝基苯基)硼酸36.7g(220mmol), [1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯[3-苯基烯丙基]钯(II)催化剂648毫克, 1.5M碳酸钠水液200ml(300mmol)和乙二醇二甲醚1000ml(DME),80℃加热搅拌过夜。冷却至室温,加入800ml水,固体析出,过滤,粗品通过硅胶柱层析法精制(洗脱液:乙酸乙酯/己烷),得到39.3g化合物2,7-双(2-硝基苯基)-9-苯基-9H-咔唑,收率81%,HPLC纯度99.6%。
1HNMR(DMSO):δ8.62(d,1H),8.31 (d,1H), 8.22(d,2H),8.03~8.00(m,4H) 7.91~7.89(m,3H),7.74~7.72(m,4H),7.62(m,2H), 7.58(m,1H),7.50(m,1H)
Figure 737915DEST_PATH_IMAGE138
(2)在氩气气氛下,反应容器中加入2,7-双(2-硝基苯基)-9-苯基-9H-咔唑48.6克(100mmol), 用100ml氯苯溶解, 加入7.9克三苯基膦,180℃加热搅拌过夜。冷却至室温,过滤,滤液减压除去溶剂,得到的粗品通过硅胶柱层析法精制(洗脱液:乙酸乙酯/己烷),得到32.9g化合物14-苯基-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑,收率78%,HPLC纯度98.6%。
1HNMR(DMSO):δ11.66(s,2H),8.19(d,2H),7.63~7.62(m,4H),7.55(s,2H), 7.50(m,4H),7.40(s,2H),7.20(m,2H)。
Figure 210354DEST_PATH_IMAGE139
(3)在氩气气氛下,反应容器中加入叔丁醇钾26.9克(240mmol), [1,3-双(2,6-二-异丙基苯基)-4,5-二氢咪唑-2-亚基]氯[3-苯基烯丙基]钯(II)催化剂648毫克(1mmol%),2-溴-3-苯基喹啉62.7g(220mmol),14-苯基-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑42.2克(100mmol)和1000mL乙二醇二甲醚(DME),在80℃加热搅拌15小时。反应混合物冷却到室温,加入500ml水,过滤,粗品通过硅胶柱层析法精制(洗脱液:乙酸乙酯/己烷),得到68.1克化合物1,HPLC纯度99.6%,收率82%.
1HNMR(DMSO):δ8.55 (d,2H),8.40(d,4H),7.94(d,2H),7.80(d,4H), 7.67(m,4H),7.62(m,2H),7.59~7.57(m,7H),7.50(m,2H), 7.47(s,4H), 7.35(m,2H),7.16(m,2H)。
实施例2
化合物5的合成
Figure 885049DEST_PATH_IMAGE140
除了起始原料更换为2,7-二溴-9-(3-苯基喹啉-2-基)-9H咔唑以外,其他与实施例1相同
1HNMR(DMSO):δ8.62(d,2H),8.40(m,3H), 8.22(m,2H),8.03~8.00(m,4H) 7.89(m,2H),7.80(m,2H),7.74(s,2H),7.72(m,2H),7.62(m,2H), 7.59~7.57(m,2H)
Figure 877275DEST_PATH_IMAGE141
除了起始原料更换为3-硝基-7-(2-硝基苯基)-2-苯基-9-(3-苯基喹啉-2-基)-9H咔唑以外,其他与实施例1相同。
1HNMR(DMSO):δ11.66(s,2H),8.40(d2H),8.19(d,2H),7.80(d,2H),7.67(m,2H),7.63(d,2H),7.59~7.57(m,3H), 7.55(s,2H),7.50(m,2H),7.40(s,2H),7.20(m,2H).
Figure 529623DEST_PATH_IMAGE142
除了起始原料更换为14-(3-苯基喹啉-2-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑以外,其他与实施例1相同。
1HNMR(DMSO):δ8.55 (d,2H),8.40(d,4H),7.94(d,2H),7.80(d,2H), 7.62(m,4H),7.59~7.57(m,5H),7.50(m,4H), 7.47(s,4H), 7.35(m,2H),7.16(m,2H)。
实施例3
化合物11的合成
Figure 443353DEST_PATH_IMAGE143
Figure 718476DEST_PATH_IMAGE144
与实施例1相同。
Figure 17739DEST_PATH_IMAGE145
除了溴代物更换为对溴吡啶以外,其他与实施例1相同。
1HNMR(DMSO):δ8.56 (d,4H),8.55(d,2H),7.94(d,2H),7.62(m,2H), 7.58(m,1H),7.50(d,6H),7.47(s,4H),7.35(d,2H),7.16(d,2H)。
实施例4
化合物19的合成
Figure 87327DEST_PATH_IMAGE146
除了起始原料更换为2,7-二溴-9-(萘-2-基)-9H咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ8.62(d,1H),8.31 (d,1H), 8.22(d,2H),8.03~8.00(m,6H)7.91~7.89(m,3H),7.74~7.72(m,4H),7.62(m,1H),7.58(m,2H),7.50(m,1H)
Figure 285090DEST_PATH_IMAGE147
除了起始原料更换为9-(萘-2-基)-2,7-双(2-硝基苯基)-9H咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),8.19(d,2H),8.03(d,3H),7.83(s,1H),7.63
(d,2H),7.59~7.58(m,2H),7.55(s,2H),7.50(m,2H),7.40(s,2H),7.36(m,1H),7.20(m,2H).
Figure 52320DEST_PATH_IMAGE148
除了起始原料更换为3-溴-1-苯基-1H-1,2,4-***和14-(萘-2-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ9.24(s,2H),8.55 (d,2H),8.03(d,3H),7.94(m,2H),7.83(s,1H),7.67
(d,4H),7.59~7.58(m,2H),7.57(m,4H),7.52(m,2H),7.47(s,4H),7.35(d,2H),7.16(d,2H)。
实施例5
化合物24的合成
Figure 284718DEST_PATH_IMAGE149
除了起始原料更换为2,7-二溴-9-(吡啶-4-基)-9H咔唑和(5-(叔丁基)-2-硝基苯基)硼酸以外,其他与实施例1相同。
1HNMR(DMSO):δ8.62(d,2H),8.56 (d,2H), 8.28(d,2H),8.22(d,2H),8.19
(s,2H),7.74(s,2H),7.67(m,2H),7.50(m,2H),1.43(s,18H).
Figure 712157DEST_PATH_IMAGE150
除了起始原料更换为2,7-二(5-(叔丁基)-2-硝基苯基)-9-(吡啶-4-基)-9H咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),8.56(d,2H),8.36(s,2H),7.62(d,2H),7.55(s,2H),
7.50(m,4H),7.40(s,2H),1.43(s,18H).
Figure 662796DEST_PATH_IMAGE151
除了起始原料更换为对溴吡啶和2,11-二叔丁基-14-(吡啶-4-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ8.95(s,2H),8.56(d,6H),7.86(d,2H),7.50(m,6H),7.47(s,6H),
7.11(d,2H),1.43(s.18H).
实施例6
化合物29的合成
Figure 14143DEST_PATH_IMAGE152
除了起始原料更换为2-(2,7-二溴-9H-咔唑-9-基)苯并[d]恶唑和(5-(叔丁基)-2-硝基苯基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ8.62(d,2H),8.28(d,2H),8.22(d,2H),8.19(s,2H),7.74(s,2H),7.72
(m,2H),7.67(m,2H),7.39(m,2H),1.43(s,18H).
Figure 786533DEST_PATH_IMAGE153
除了起始原料更换为2-(2,7-二(5-(叔丁基)-2-硝基苯基)-9H-咔唑-9-基)苯并[d]恶唑以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),8.36(s,2H),7.72(m,2H),7.62(m,2H),7.55(s,2H),
7.50(d,2H),7.40(s,2H),7.39(m,2H),1.43(s,18H).
Figure 401185DEST_PATH_IMAGE154
除了起始原料更换为2-溴苯并[d]恶唑,2-(2,11-二叔丁基-5,8-二氢-14H-吡咯[3,2-b:4,5-b']二咔唑-14-基)苯并[d]恶唑以外,其他与实施例1相同。
1HNMR (DMSO):δ8.95(s,2H),8.36(d,6H),7.86(d,2H),7.72(m,6H), 7.47(s,6H),7.39
(m,6H),7.11(d,2H),1.43(s.18H).
实施例7
化合物38的合成
Figure 307961DEST_PATH_IMAGE155
除了起始原料更换为2,7-二溴-9-(吡啶-4-基)-9H咔唑和(3-硝基吡啶-2-基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ8.76(d,2H),8.62 (m,4H), 8.56(d,2H),8.30 (d,2H), 8.13(s,2H),
7.50(d,2H),7.27(m,2H)
Figure 712267DEST_PATH_IMAGE156
除了起始原料更换为2,7-二(3-硝基吡啶-2-基)-9-(吡啶-4-基)-9H咔唑以外,其他与实施例1相同。
1HNMR(DMSO):δ11.66(s,2H),9.34(s,2H),8.56(m,2H),8.43(m,2H),7.55(s,2H),7.50
(d,2H),7.46(d,2H),7.40(s,2H).
Figure 856940DEST_PATH_IMAGE157
除了起始原料更换为对溴吡啶和14-(吡啶-4-基)-8,14-二氢-5H-吡啶[3',4':4':4,5]吡咯[3,2-b]吡啶[3',4':4,5]吡咯[2,3-h]咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ8.56 (d,6H),8.43(m,3H),7.97(d,2H),7.55(s,2H),7.50(m,6H),
7.40(s,2H),7.22(m,2H)
实施例8
化合物43的合成
Figure 704811DEST_PATH_IMAGE158
除了起始原料更换为2-(2,7-二溴-9H-咔唑-9-基)苯并[d]恶唑(3-硝基吡啶-2-基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ8.76(d,2H),8.62(m,2H),8.30(m,4H),8.13(s,2H),7.72(m,2H),7.39
(m,2H),7.27(m,2H).
Figure 52877DEST_PATH_IMAGE159
除了起始原料更换为2-(2,7-双(3-硝基吡啶-2-基)-9H-咔唑-9-基)苯并[d]恶唑以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),9.34(s,2H),8.43(m,2H),7.72(m,2H),7.55(s,2H),7.46
(m,2H),7.40(s,2H),7.39(m,2H).
Figure 11606DEST_PATH_IMAGE160
除了起始原料更换为2-溴苯并[d]恶唑,2-(5,8-二氢-14H-吡啶[3',4':4,5]吡咯[3,2-b]吡啶[3',4':4,5]吡咯[2,3-h]咔唑-14-基)苯并[d]恶唑以外,其他与实施例1相同。
1HNMR (DMSO):δ8.43(m,2H),7.97(d,2H),7.72(m,6H),7.55(s,2H), 7.40(s,2H),7.39
(m,6H),7.22(m,2H).
实施例9
化合物46的合成
Figure 260054DEST_PATH_IMAGE161
除了起始原料更换为2,7-二溴-9-(异喹啉-3-基)-9H咔唑45.2克(100mmol), (4-硝基吡啶-3-基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ9.50(s,2H),9.46(s,1H),8.62(d,2H),8.29(d,2H),8.22(m,2H),8.05
(d,2H),7.98(d,1H),7.74(s,2H),7.68(m,1H),7.64(m,1H),7.62(s,1H).
Figure 278825DEST_PATH_IMAGE162
除了起始原料更换为9-(异喹啉-3-基)-2,7-双(4-硝基吡啶-3-基)-9H咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),9.46(s,1H),9.34(s,2H),8.43(m,2H),7.98(d,
1H),7.68(m,1H),7.64(d,1H),7.62(s,1H),7.57(m,1H),7.55(s,2H),7.46(d,2H),7.40(s,2H).
Figure 894615DEST_PATH_IMAGE163
除了起始原料更换为2-溴喹啉和14-(异喹啉-3-基)-8,14-二氢-5H-吡啶[3',4':4,5]吡咯[3,2-b]吡咯[3',4':4,5]吡咯[2,3-h]咔唑以外,其他与实施例1相同。
1HNMR(DMSO):δ9.46(s,1H),9.34(s,2H),8.43(d,2H),8.35(d,2H),8.03(d,2H),8.00(d,2H),
7.98(d,1H),7.96(d,2H),7.83(m,2H),7.68(m,1H),7.64(d,1H),7.62(s,1H),7.57(m,1H),7.53(m,2H),7.51(d,2H),7.47(s,4H).
实施例10
化合物54的合成
Figure 336661DEST_PATH_IMAGE164
除了起始原料更换为2,7-二溴-9-(喹啉-5-基)-9H咔唑和(4-硝基吡啶-3-基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ9.50(s,2H),8.95(d,1H),8.62(d,2H),8.46(d,1H),8.29(d,2H),8.22
(m,2H),8.12(d,1H),8.05(d,2H),8.00(m,1H),7.92(d,1H),7.74(s,2H),7.63(m,1H).
Figure 252664DEST_PATH_IMAGE165
除了起始原料更换为2,7-双(4-硝基吡啶-3-基)-9-(喹啉-5-基)-9H咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),9.34(s,2H),8.95(d,1H),8.46(d,1H),8.43(d,2H),8.12
(d,1H),8.00(m,1H),7.92(d,1H),7.63(m,1H),7.55(s,2H),7.46(d,2H),7.40(s,2H).
Figure 176758DEST_PATH_IMAGE166
除了起始原料更换为5-溴喹啉和14-(喹啉-5-基)-8,14-二氢-5H-吡啶[3',4':4,5]吡咯[3,2-b]吡咯[3',4':4,5]吡咯[2,3-h]咔唑以外,其他与实施例1相同。
1HNMR(DMSO):δ9.34(s,2H),8.95(d,3H),8.46(d,3H),8.35(d,2H),8.12(d,2H),8.00
(m,3H),7.92(d,3H),7.63(m,3H),7.51(d,2H),7.47(s,4H)。
实施例11
化合物68的合成
Figure 997952DEST_PATH_IMAGE167
除了起始原料更换为2,7-二溴-9-(吡啶-4-基)-9H咔唑和(5-氰基-2-硝基苯基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ8.62(s,2H),8.56 (d,2H), 8.54(d,2H),8.22(d,2H), 8.11(s,2H),7.96
(d,2H),7.74(s,2H),7.50(d,2H).
Figure 298483DEST_PATH_IMAGE168
除了起始原料更换为3,3'-(9-(吡啶-4-基)-9H-咔唑-2,7-二酰基)双(4-硝基苯甲腈)以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),8.56(m,2H),7.80(s,2H),7.76(d,2H), 7.50(d,2H),7.55
(s,2H),7.50(d,2H),7.40(s,2H),7.33(d,2H).
Figure 6676DEST_PATH_IMAGE169
除了起始原料更换为4-溴吡啶34.8g(220mmol),14-(吡啶-4-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑-2,11-二甲腈以外,其他与实施例1相同。
1HNMR (DMSO):δ8.56 (d,6H),8.12(d,2H),7.80(s,2H),7.50(d,6H),7.47(s,4H),7.33(d,2H).
实施例12
化合物88的合成
Figure 117983DEST_PATH_IMAGE170
除了起始原料更换为2,7-二溴-9-(吡嗪-2-基)-9H咔唑40.3克(100mmol), (4-硝基吡啶-3-基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ9.50(s,2H),8.83 (m,1H), 8.82(s,1H),8.76(d,1H), 8.62(d,2H),8.29
(d,2H),8.22(d,2H),8.05(d,2H),7.74(s,2H).
Figure 708364DEST_PATH_IMAGE171
除了起始原料更换为2,7-双(4-硝基吡啶-3-基)-9-(吡嗪-2-基)-9H咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),9.34(s,2H), 8.83 (m,1H), 8.82(s,1H),8.76(d,
1H), 8.43(d,2H),7.55(s,2H),7.46(d,2H),7.40(s,2H).
Figure 15849DEST_PATH_IMAGE172
除了起始原料更换为2-溴吡嗪35.0g(220mmol),14-(吡啶-4-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ9.34 (s,2H), 8.83 (m,3H), 8.82(s,3H),8.76(d,3H), 8.35(d,2H),
7.51(d,2H),7.47(s,4H).
实施例13
化合物93的合成
Figure 93395DEST_PATH_IMAGE173
除了起始原料更换为2,7-二溴-9-(4-(吡啶-4-基)苯基)-9H咔唑47.8克(100mmol), (3-硝基吡啶-2-基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ8.76(d,2H),8.71 (d,2H), 8.62(s,4H),8.30(d,2H), 8.13(s,2H),8.00
(d,2H),7.92(d,2H),7.91(d,2H),7.27(d,2H).
Figure 359291DEST_PATH_IMAGE174
除了起始原料更换为2,7-双(3-硝基吡啶-2-基)-9-(4-(吡啶-4-基)苯基)-9H咔唑以外,其他与实施例1相同。
1HNMR(DMSO):δ11.66(s,2H),9.34(s,2H), 8.71 (d,2H), 8.43(d,2H), 8.00(d,2H),7.92(d,2H),7.91(d,2H),7.55(s,2H),7.46(d,2H),7.40(s,2H).
Figure 702548DEST_PATH_IMAGE175
除了起始原料更换为4-(4-溴苯基)吡啶51.5g(220mmol),14-(4-(吡啶-4-基)苯基)-8,14-二氢-5H-吡啶[3',4':4,5]吡咯[3,2-b]吡咯[3',4':4,5]吡咯[2,3-h]咔唑以外,其他与实施例1相同。
1HNMR(DMSO):δ8.71 (d,6H), 8.43 (d,2H),8.00(d,6H),7.97(d,2H),7.92(d,6H),7.91(d,6H),7.55(s,2H),7.46(d,2H),7.40(s,2H),7.22(d,2H)。
实施例14
化合物145的合成
Figure 30368DEST_PATH_IMAGE176
除了起始原料更换为2-(2,7-二溴-9H-咔唑-9-基)-1,10-菲罗啉以外,其他与实施例1相同。
1HNMR (DMSO):δ8.80 (d,1H), 8.62 (d,2H), 8.45(d,2H),8.22(d,1H),8.14(d,1H),8.03
(d,3H),8.00(d,2H),7.89(d,2H), 7.46(d,2H),7.56(m,1H),7.47(s,4H).
Figure 509891DEST_PATH_IMAGE177
除了起始原料更换为2-(2,7-双(2-硝基苯基)-9H-咔唑-9-基)-1,10-菲罗啉以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66 (s,2H), 8.80 (d,1H), 8.45(d,2H),8.22(d,1H),8.19(d,
2H),8.14(d,1H),7.89(d,2H),7.63(d,2H),7.55(m,3H),7.50(m,2H),7.40(s,4H),7.20(m,2H).
Figure 212268DEST_PATH_IMAGE178
除了起始原料更换为溴苯和14-(1,10-菲咯啉-2-基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ8.80 (d,1H), 8.55(d,2H),8.45(d,2H),8.03(d,1H),7.94(d,2H),7.89
(d,1H),7.62(m,4H),7.58(m,2H),7.56(m,1H),7.50(m,4H),7.47(s,4H),7.35(m,2H),7.16(m,2H).
实施例15
化合物148的合成
Figure 229771DEST_PATH_IMAGE179
除了起始原料更换为2-(2,7-二溴-9H-咔唑-9-基)-1,10-菲罗啉和(4-硝基-[1,1'-联苯]-3-基)硼酸以外,其他与实施例1相同。
1HNMR (DMSO):δ8.80(d,1H),8.45(d,2H),8.32(d,2H),8.14(d,1H),8.03(d,1H),7.99(d,2H),
7.89(s,2H),7.77(d,2H),7.75(d,4H),7.56(m,1H),7.55(s,2H),7.49(m,4H),7.41(m,2H),7.40(s,2H),
7.34(d,2H).
Figure 675796DEST_PATH_IMAGE180
除了起始原料更换为2-(2,7-双(4-硝基-[1,1'-联苯]-3-基)-9H-咔唑-9-基)-1,10-菲罗啉以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),8.80(d,1H),8.45(d,2H),8.14(d,1H),8.03(d,1H),7.99(d,2H),
7.89(s,2H),7.77(d,2H),7.75(d,4H),7.56(m,1H),7.55(s,2H),7.49(m,4H),7.41(m,2H),7.40(s,2H).
Figure 229399DEST_PATH_IMAGE181
除了起始原料更换为14-(1,10-菲咯啉-2-基)-2,11-二苯基-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑和2-溴苯以外,其他与实施例1相同。
1HNMR (DMSO):δ8.80(d,1H),8.45 (d,2H), 8.30(d,2H),8.14(d,3H),8.03(d,1H),7.89(d,3H),
7.75(d,4H),7.62(m,4H),7.58(m,2H),7.56(m,1H),7.50(d,4H),7.49(m,4H),7.47(s,4H),7.41(m,2H)。
实施例16
化合物184的合成
Figure 837098DEST_PATH_IMAGE182
除了起始原料更换为9-(3-(1,8-萘啶-4-基)苯基)-2,7-二溴-9H-咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ8.89(d,1H),8.70(d,1H),8.62(d,2H),8.39(d,1H),8.22(m,2H),8.03(d,2H),
8.00(d,2H),7.89(m,2H),7.79(d,1H),7.74(s,2H),7.72(m,2H),7.68(m,1H),7.60(d,1H),7.47(d,1H),
7.41(m,2H).
Figure 889368DEST_PATH_IMAGE183
除了起始原料更换为9-(3-(1,8-萘啶-4-基)苯基)-2,7-双(2-硝基苯基)-9H咔唑以外,其他与实施例1相同。
1HNMR (DMSO):δ11.66(s,2H),8.89(d,1H),8.70 (d,1H), 8.39(d,1H),8.21(s,1H),8.19
(d,2H),7.79(d,1H),7.68(m,1H),7.63(d,2H),7.60(d,1H),7.55(s,2H),7.50(m,2H),7.47(d,1H),
7.41(m,1H),7.40(s,2H),7.20(m,2H).
Figure 326034DEST_PATH_IMAGE184
除了起始原料更换为14-(3-(1,8-萘啶-4-基)苯基)-8,14-二氢-5H-吡咯[3,2-b:4,5-b']二咔唑和2-溴萘以外,其他与实施例1相同。
1HNMR(DMSO):δ8.89(d,1H),8.70 (d,1H), 8.39(d,1H),8.21(s,1H),8.19(d,2H),8.03(m,6H),7.83(s,2H),7.79(d,2H),7.68(m,1H),7.59(m,2H),7.58(m,4H),7.50(m,2H),7.47(m,5H),7.41(m,1H),7.36(d,2H),7.20(m,2H).
器件实施方案
发光材料器件的评价
器件实施例和对比例中所用的各有机层化合物如下所示:
Figure 780149DEST_PATH_IMAGE185
Figure 824329DEST_PATH_IMAGE186
Figure 320819DEST_PATH_IMAGE187
Figure 843067DEST_PATH_IMAGE188
Figure 354951DEST_PATH_IMAGE189
Figure 553720DEST_PATH_IMAGE190
Figure 49423DEST_PATH_IMAGE191
实施例17
本发明有机光电器件的基本结构模型为:
ITO/HAT-CN (10 nm)/TAPC (40 nm)/TCTA(10 nm)/EML(本发明的化合物):RD(Ir配合物)=94:6 (40nm)/ETL(30nm)/LiF(1nm)/Al(80nm)。
本发明有机光电器件的制造方法:
(1)依次用丙酮、乙醇和蒸馏水对透明阳极氧化铟锡(ITO)20(10Ω/sq)玻璃基板进行超声清洗,再用臭氧等离子处理15分钟。
(2)在真空气相蒸镀设备的衬底固定器上安装ITO衬底后,控制体系压力在10-6托,接着向ITO衬底上依次蒸镀厚度为10nm的HAT-CN,40nm的TAPC和10nm的TCTA。
(3)在上述TCTA上蒸镀厚度为40nm的发光层(EML),其中本发明化合物1与RD的质量比为94:6。
(4)在上述发光层上蒸镀厚度为30nm的电子传输层(ETL)材料。
(5)在上述电子传输层上蒸镀厚度为1nm的LiF作为电子注入层。
(6)最后在上述电子注入层上蒸镀厚度为80nm的Al作为阴极,且利用玻璃封装盖对器件进行封装。
器件测试结果见表1。
实施例18
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物5。器件测试结果见表1。
实施例19
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物11。器件测试结果见表1。
实施例20
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物19。器件测试结果见表1。
实施例21
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物24。器件测试结果见表1。
实施例22
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物29。器件测试结果见表1。
实施例23
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物38。器件测试结果见表1。
实施例24
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物43。器件测试结果见表1。
实施例25
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物46。器件测试结果见表1。
实施例26
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物54。器件测试结果见表1。
实施例27
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物68。器件测试结果见表1。
实施例28
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物88。器件测试结果见表1。
实施例29
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物93。器件测试结果见表1。
实施例30
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物145。器件测试结果见表1。
实施例31
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物148。器件测试结果见表1。
实施例32
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物184。器件测试结果见表1。
对比例1
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物RH-01。器件测试结果见表1。
对比例2
本实施例中器件的制造与实施例17相同,除了发光层(EML)主体材料为化合物RH-02。器件测试结果见表1。
表1显示了实施例17-32及对比例1-2中器件的性能测试结果
表1
Figure 375362DEST_PATH_IMAGE192
上述实施例和对比例中的器件结构除了发光层不同外,其它均一致,基于RH-01和RH-02的器件性能为参考,包含本发明的三并咔唑衍生物的器件的电流效率有了显著提升,同时其寿命也有所提升。综上所述,本发明的新颖的咔唑衍生物在有机光电器件上具有有较大的应用价值。
以上描述了本发明的基本原理、主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等同物界定。

Claims (6)

1.三并咔唑衍生物,其具有下列式(1)所示的结构:
Figure DEST_PATH_IMAGE001
式(1)
X1-X8各自独立地选自CR或N原子,其中R选自氢、氘、卤素、氰基、取代或未取代的烷基、环烷基、杂烷基杂环烷基或芳基或杂芳基;
X1-X8彼此相同或不同,其中当X1-X8均不为N原子时,R1、R2和R3不全相同或全部不相同;
L1、L2和L3各自独立地为单键或取代或未取代的芳基;
R1、R2和R3各自独立地选自取代或未取代的C6~C30芳基、取代或未取代的C4~C30杂芳基或与邻近的原子键合成环;
R4和R5各自独立地选自氢、取代或未取代的 C1-C15烷基、取代或未取代的C6~C30芳基或取代或未取代的C4~C30杂芳基;
其中,R1、R2和R3中至少一者选自如下取代或未取代的基团,
Figure DEST_PATH_IMAGE002
Figure DEST_PATH_IMAGE003
Figure DEST_PATH_IMAGE004
Figure DEST_PATH_IMAGE005
Figure DEST_PATH_IMAGE006
Figure DEST_PATH_IMAGE007
Figure DEST_PATH_IMAGE008
Figure DEST_PATH_IMAGE009
Figure DEST_PATH_IMAGE010
Figure DEST_PATH_IMAGE011
Figure DEST_PATH_IMAGE012
Figure DEST_PATH_IMAGE013
Figure DEST_PATH_IMAGE014
Figure DEST_PATH_IMAGE015
Figure DEST_PATH_IMAGE016
Figure DEST_PATH_IMAGE017
Figure DEST_PATH_IMAGE018
Figure DEST_PATH_IMAGE019
Figure DEST_PATH_IMAGE020
Figure DEST_PATH_IMAGE021
Figure DEST_PATH_IMAGE022
Figure DEST_PATH_IMAGE023
Figure DEST_PATH_IMAGE024
Figure DEST_PATH_IMAGE025
Figure DEST_PATH_IMAGE026
Figure DEST_PATH_IMAGE027
其中,R6-R10各自独立地选自氢、取代或未取代的 C1-C15烷基、取代或未取代的C6~C30芳基或取代或未取代的C4~C30杂芳基;
并且当R1为上述S-44,且R2和R3不为上述S-44时,L1为单键;
当R2为上述S-44,且R1和R3不为上述S-44时,L2为单键;
当R3为上述S-44,且R1和R2不为上述S-44时,L3为单键。
2.根据权利要求1所述的三并咔唑衍生物,其中所述三并咔唑衍生物为以下结构中任一者:
Figure DEST_PATH_IMAGE028
Figure DEST_PATH_IMAGE029
Figure DEST_PATH_IMAGE030
Figure DEST_PATH_IMAGE031
Figure DEST_PATH_IMAGE032
Figure DEST_PATH_IMAGE033
Figure DEST_PATH_IMAGE034
Figure DEST_PATH_IMAGE035
Figure DEST_PATH_IMAGE036
Figure DEST_PATH_IMAGE037
Figure DEST_PATH_IMAGE038
Figure DEST_PATH_IMAGE039
Figure DEST_PATH_IMAGE040
Figure DEST_PATH_IMAGE041
Figure DEST_PATH_IMAGE042
Figure DEST_PATH_IMAGE043
Figure DEST_PATH_IMAGE044
Figure DEST_PATH_IMAGE045
Figure DEST_PATH_IMAGE046
Figure DEST_PATH_IMAGE047
Figure DEST_PATH_IMAGE048
Figure DEST_PATH_IMAGE049
Figure DEST_PATH_IMAGE050
Figure DEST_PATH_IMAGE051
Figure DEST_PATH_IMAGE052
Figure DEST_PATH_IMAGE053
Figure DEST_PATH_IMAGE054
Figure DEST_PATH_IMAGE055
Figure DEST_PATH_IMAGE056
Figure DEST_PATH_IMAGE057
Figure DEST_PATH_IMAGE058
Figure DEST_PATH_IMAGE059
Figure DEST_PATH_IMAGE060
Figure DEST_PATH_IMAGE061
Figure DEST_PATH_IMAGE062
Figure DEST_PATH_IMAGE063
Figure DEST_PATH_IMAGE064
Figure DEST_PATH_IMAGE065
Figure DEST_PATH_IMAGE066
Figure DEST_PATH_IMAGE067
Figure DEST_PATH_IMAGE068
Figure DEST_PATH_IMAGE069
Figure DEST_PATH_IMAGE070
Figure DEST_PATH_IMAGE071
Figure DEST_PATH_IMAGE072
Figure DEST_PATH_IMAGE073
Figure DEST_PATH_IMAGE074
Figure DEST_PATH_IMAGE075
Figure DEST_PATH_IMAGE076
Figure DEST_PATH_IMAGE077
Figure DEST_PATH_IMAGE078
Figure DEST_PATH_IMAGE079
Figure DEST_PATH_IMAGE080
Figure DEST_PATH_IMAGE081
Figure DEST_PATH_IMAGE082
Figure DEST_PATH_IMAGE083
Figure DEST_PATH_IMAGE084
Figure DEST_PATH_IMAGE085
Figure DEST_PATH_IMAGE086
Figure DEST_PATH_IMAGE087
Figure DEST_PATH_IMAGE088
Figure DEST_PATH_IMAGE089
Figure DEST_PATH_IMAGE090
Figure DEST_PATH_IMAGE091
Figure DEST_PATH_IMAGE092
Figure DEST_PATH_IMAGE093
Figure DEST_PATH_IMAGE094
Figure DEST_PATH_IMAGE095
Figure DEST_PATH_IMAGE096
Figure DEST_PATH_IMAGE097
Figure DEST_PATH_IMAGE098
Figure DEST_PATH_IMAGE099
Figure DEST_PATH_IMAGE100
Figure DEST_PATH_IMAGE101
Figure DEST_PATH_IMAGE102
Figure DEST_PATH_IMAGE103
Figure DEST_PATH_IMAGE104
Figure DEST_PATH_IMAGE105
Figure DEST_PATH_IMAGE106
Figure DEST_PATH_IMAGE107
Figure DEST_PATH_IMAGE108
Figure DEST_PATH_IMAGE109
Figure DEST_PATH_IMAGE110
Figure DEST_PATH_IMAGE111
Figure DEST_PATH_IMAGE112
Figure DEST_PATH_IMAGE113
Figure DEST_PATH_IMAGE114
Figure DEST_PATH_IMAGE115
Figure DEST_PATH_IMAGE116
Figure DEST_PATH_IMAGE117
Figure DEST_PATH_IMAGE118
Figure DEST_PATH_IMAGE119
Figure DEST_PATH_IMAGE120
Figure DEST_PATH_IMAGE121
Figure DEST_PATH_IMAGE122
Figure DEST_PATH_IMAGE123
Figure DEST_PATH_IMAGE124
Figure DEST_PATH_IMAGE125
Figure DEST_PATH_IMAGE126
Figure DEST_PATH_IMAGE127
Figure DEST_PATH_IMAGE128
Figure DEST_PATH_IMAGE129
3.有机光电器件,其包括阴极层、阳极层和有机层,
其中,所述有机层为空穴注入层、空穴传输层、发光层、电子注入层或电子传输层中至少一层,其中,所述有机层包含权利要求1或2所述的三并咔唑衍生物。
4.根据权利要求3所述的有机光电器件,其中所述有机层为发光层,所述发光层中还包含掺杂剂,其中所述三并咔唑衍生物与所述掺杂剂的质量比为1:99~99:1。
5.根据权利要求3所述的有机光电器件,其中所述有机光电器件为有机光伏器件、有机发光器件、有机太阳电池、电子纸、有机感光体、有机薄膜晶体管或有机内存器件。
6.显示或照明装置,其包括权利要求3所述的有机光电器件。
CN202111001493.7A 2021-08-30 2021-08-30 三并咔唑衍生物、有机光电器件及显示或照明装置 Pending CN113444097A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111001493.7A CN113444097A (zh) 2021-08-30 2021-08-30 三并咔唑衍生物、有机光电器件及显示或照明装置

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111001493.7A CN113444097A (zh) 2021-08-30 2021-08-30 三并咔唑衍生物、有机光电器件及显示或照明装置

Publications (1)

Publication Number Publication Date
CN113444097A true CN113444097A (zh) 2021-09-28

Family

ID=77818891

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111001493.7A Pending CN113444097A (zh) 2021-08-30 2021-08-30 三并咔唑衍生物、有机光电器件及显示或照明装置

Country Status (1)

Country Link
CN (1) CN113444097A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023210192A1 (ja) * 2022-04-28 2023-11-02 株式会社Kyulux 化合物、発光材料および有機発光素子

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102754238A (zh) * 2010-02-12 2012-10-24 新日铁化学株式会社 有机电致发光元件
CN106397398A (zh) * 2016-08-31 2017-02-15 北京绿人科技有限责任公司 一种有机化合物及其在有机电致发光器件中的应用
CN106467526A (zh) * 2016-08-26 2017-03-01 江苏三月光电科技有限公司 一种含有氧杂蒽的有机化合物及其应用
CN106467522A (zh) * 2016-07-25 2017-03-01 江苏三月光电科技有限公司 一种含有三嗪类化合物的有机电致发光器件及其应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102754238A (zh) * 2010-02-12 2012-10-24 新日铁化学株式会社 有机电致发光元件
CN106467522A (zh) * 2016-07-25 2017-03-01 江苏三月光电科技有限公司 一种含有三嗪类化合物的有机电致发光器件及其应用
CN106467526A (zh) * 2016-08-26 2017-03-01 江苏三月光电科技有限公司 一种含有氧杂蒽的有机化合物及其应用
CN106397398A (zh) * 2016-08-31 2017-02-15 北京绿人科技有限责任公司 一种有机化合物及其在有机电致发光器件中的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023210192A1 (ja) * 2022-04-28 2023-11-02 株式会社Kyulux 化合物、発光材料および有機発光素子

Similar Documents

Publication Publication Date Title
CN112125872B (zh) 杂环化合物和使用其的有机发光器件
KR102267451B1 (ko) 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
KR20100109060A (ko) 신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계발광 소자
JP6097338B2 (ja) 燐光ホスト用化合物及びこれを含んだ有機発光素子
TW201509872A (zh) 用於有機電子材料之新穎化合物及使用該化合物之有機電子裝置
KR20100118700A (ko) 신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
KR20100109293A (ko) 신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계발광 소자
CN113563871B (zh) 主体材料、有机光电器件及显示或照明装置
KR20140098050A (ko) 벤조플루오렌 화합물, 그 화합물을 사용한 발광층용 재료 및 유기 전계 발광 소자
CN113402507B (zh) 三亚苯衍生物,发光器件材料及发光器件
KR20150012974A (ko) 새로운 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자
KR20190037925A (ko) 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
KR20190049525A (ko) 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
CN113817462B (zh) 主体材料、有机光电器件及显示或照明装置
CN113840822A (zh) 杂环化合物以及包括其的有机发光装置
CN113429399B (zh) 芘类衍生物,发光器件材料及发光器件
KR101896009B1 (ko) 인데노플루오렌을 포함하는 유기전기소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
CN116514752B (zh) 一种发光辅助材料及制备方法与其在有机电致发光器件中的应用
CN113444097A (zh) 三并咔唑衍生物、有机光电器件及显示或照明装置
KR20210049544A (ko) 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
CN113717181B (zh) 主体材料、有机光电器件及显示或照明装置
KR101319631B1 (ko) 아자인데노안트라센 유도체 및 이를 이용한 유기 전계 발광 소자
CN114716418A (zh) 杂环烷烃衍生物、有机光电器件和显示或照明装置
KR101554859B1 (ko) 신규한 유기 전자재료용 화합물 및 이를 포함하는 유기 전자 소자
KR102580638B1 (ko) 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210928